{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:13:14Z","timestamp":1785791594051,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jogc.2017.10.024","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T04:27:55Z","timestamp":1525926475000},"page":"910-918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review"],"prefix":"10.1016","volume":"40","author":[{"given":"Melissa","family":"Lavecchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Chari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2017.10.024_bib0010","first-page":"e163","article-title":"Prevalence of nausea and vomiting of pregnancy in the USA: a meta analysis","volume":"20","author":"Einarson","year":"2013","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0015","first-page":"e171","article-title":"Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis","volume":"20","author":"Einarson","year":"2013","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1701-2163(16)30475-3","article-title":"The management of nausea and vomiting of pregnancy","volume":"24","author":"Arsenault","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.10.024_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/01.AOG.0000471177.80067.19","article-title":"Practice Bulletin Summary No. 153: Nausea and Vomiting of Pregnancy","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0030","doi-asserted-by":"crossref","first-page":"d3606","DOI":"10.1136\/bmj.d3606","article-title":"Management of nausea and vomiting in pregnancy","volume":"342","author":"Jarvis","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2017.10.024_bib0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3109\/14767058.2011.598588","article-title":"Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum","volume":"25","author":"Mullin","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2017.10.024_bib0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2008-1040344","article-title":"Secular trends in the treatment of hyperemesis gravidarum","volume":"25","author":"Goodwin","year":"2008","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0045","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/pds.4185","article-title":"Antiemetic use among pregnant women in the United States: the escalating use of ondansetron","volume":"26","author":"Taylor","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jogc.2017.10.024_bib0050","doi-asserted-by":"crossref","first-page":"909860","DOI":"10.1155\/2013\/909860","article-title":"Off-label use of ondansetron in pregnancy in Western Australia","volume":"2013","author":"Colvin","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jogc.2017.10.024_bib0055","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1471-0528.2004.00236.x","article-title":"The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study","volume":"111","author":"Einarson","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2017.10.024_bib0060","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0000000000000479","article-title":"Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial","volume":"124","author":"Oliveira","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0065","author":"Inc"},{"key":"10.1016\/j.jogc.2017.10.024_bib0070","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/AOG.0000000000001388","article-title":"Ondansetron use in pregnancy and birth defects: a systematic review","volume":"127","author":"Carstairs","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0075","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jogc.2017.10.024_bib0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(10)70065-7","article-title":"Systematic reviews: CRD's guidance for undertaking reviews in health care","volume":"10","author":"Tacconelli","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jogc.2017.10.024_bib0085","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00228-005-0055-1","article-title":"Use of antiemetic drugs during pregnancy in Sweden","volume":"61","author":"Asker","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects","volume":"94","author":"Anderka","year":"2012","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0095","first-page":"e1","article-title":"Ondansetron use during pregnancy: a case series","volume":"19","author":"Ferreira","year":"2012","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0100","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2017.10.024_bib0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2014.10.017","article-title":"Use of ondansetron during pregnancy and congenital malformations in the infant","volume":"50","author":"Danielsson","year":"2014","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.jogc.2017.10.024_bib0110","article-title":"The safety of ondansetron and chlorpromazine for hyperemesis gravidarum in first trimester pregnancy","volume":"20","author":"\u00d6zdemirci","year":"2016","journal-title":"Gynecol Obstet Reprod Med"},{"key":"10.1016\/j.jogc.2017.10.024_bib0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/aje\/kwu096","article-title":"Medication use in pregnancy in relation to the risk of isolated clubfoot in offspring","volume":"180","author":"Werler","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.reprotox.2016.04.027","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States","volume":"62","author":"Fejzo","year":"2016","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0125","series-title":"Langman's medical embryology","author":"Sadler","year":"2015"},{"key":"10.1016\/j.jogc.2017.10.024_bib0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.reprotox.2016.12.001","article-title":"Publishing negative findings and the challenge of avoiding type II errors in studies of suspect teratogens: example of a recent ondansetron publication","volume":"67","author":"Edlavitch","year":"2017","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jogc.2017.10.024_bib0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.siny.2013.09.007","article-title":"The National Birth Defects Prevention Study: how to communicate data","volume":"19","author":"Scialli","year":"2014","journal-title":"Semin Fetal Neonatal Med"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317307570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317307570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:32:42Z","timestamp":1761665562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216317307570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1701216317307570"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2017.10.024","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2017.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}